One of the most prolific industries for counterfeits, the global trade in pharmaceutical counterfeit drugs is currently valued at ~ $300bn (Journal of Global Health, 2022). Meanwhile, the WHO suggests that counterfeit pharmaceuticals are responsible for an annual death toll of over 1m people annually (World Health Organization, 2019).
Counterfeit pharmaceutical products may be disguised using established and widely recognised brand names, logos and packaging, or counterfeit packaging that attempts to replicate existing labelling in order to trick customers into purchasing them. However, it is not just the packaging that is manufactured illegally. Counterfeiters may produce drugs that contain no active ingredients, incorrect amounts, or incorrect ingredients, posing serious threats to public safety.
With counterfeit medicine cited as one of the world’s fastest growing criminal enterprises (Journal of Global Medicine, 2022), it is apparent that pharmaceutical companies must act now to achieve individual product level authentication and safeguard public health.